IGRA (interferon gamma release assay)
PerkinElmer's Oxford Immunotec Gains FDA Go-Ahead for TB Test Automation
The PerkinElmer subsidiary said its T-Cell Select reagent kit reduces hands-on lab work and cost and simplifies blood sample storage.
Molecular TB Assay From PBD Biotech Shows Promise in Detecting Latent-to-Active Disease Risk
The blood-based assay, called Actiphage, combines phage-induced lysis of infectious bacteria and molecular detection of bacterial DNA.
Qiagen Next-Gen QuantiFeron Tuberculosis Test Gains Chinese Regulatory Approval
The new approval for QuantiFeron-TB Gold Plus adds to prior regulatory approvals in the US and other countries around the world, including CE-IVD marking.
Qiagen Obtains CE Mark for Assay Measuring T-Cell Response to SARS-CoV-2
Qiagen said its IGRA T-cell test can contribute insights into the immune response to a SARS-CoV-2 infection that go beyond what serology testing alone can provide.
Qiagen, DiaSorin Obtain FDA Approval for Latent TB Test on Benchtop Platform
The approval broadens accessibility in the US to a highly automated workflow for latent TB testing using a blood-based assay and benchtop platform.